Life Sciences/Biotech

FDA Approves New Alzheimer’s Treatment From Eli Lilly

WASHINGTON DC - The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's decline in patients facing the early stages of the disease. Branded as Kisunla by drugmaker Eli Lilly, donanemab's approval follows

By |2024-07-02T17:49:22-04:00July 2nd, 2024|Featured, Life Sciences, Life Sciences/Biotech|

Medical Devices Maker Stryker To Acquire Artelon

KALAMAZOO–Stryker Corp. announced an agreement to acquire all of the shares of Artelon Inc., a Marietta, Ga.-based privately held maker of soft tissue fixation products for foot and ankle and sports medicine procedures. Stryker officials said the company will strengthen its offerings in the soft tissue fixation segment and highlights Stryker’s commitment to providing differentiated

By |2024-06-12T14:51:26-04:00June 12th, 2024|Life Sciences, Life Sciences/Biotech|

New Drug To Cure Sleep Apnea End CPAP Machines

NEW YORK - A new drug could put an end to cumbersome CPAP machines, which are thought to be used by some 33 million Americans to manage their sleep apnea. Roughly 39 million Americans, including President Biden, currently suffer from sleep apnea. The most common form of the disorder is obstructive sleep apnea. In OSA patients, the

By |2024-09-23T17:36:00-04:00June 1st, 2024|Featured, Life Sciences, Life Sciences/Biotech|

Personalised Cancer Cure Gets Clinical Trials

LONDON - Thousands of NHS patients will be given access to groundbreaking cancer vaccines, health leaders have said, as a 55-year-old man became the first in England to receive the treatment for bowel cancer in a “landmark moment”. Thirty hospitals have so far signed up to NHS England’s Cancer Vaccine Launch Pad, which is working to fast-track patients to receive the vaccines at the earliest opportunity

By |2024-06-01T14:43:02-04:00June 1st, 2024|Featured, Life Sciences, Life Sciences/Biotech|

New Vaccine Helps Immune System Fight Deadly Brain Tumors

GAINESVILLE, Fla - Glioblastoma is the most common type of brain cancer, affecting about 3 in every 100,000 people globally each year. Recent research shows that glioblastoma incidence is risingTrusted Source due to an aging population and environmental factors such as air pollutionTrusted Source. Glioblastoma is a challenging cancer to treat and has an average five-year survival rate of 6.9%. Now, researchers from

By |2024-05-10T16:31:18-04:00May 10th, 2024|Life Sciences, Life Sciences/Biotech|

New Drug Candidate Could Cure Pancreatic Cancer

SAN FRANCISCO - UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition. Pancreatic cancer is less common than these other cancers, but the lack of treatment options makes it more deadly, and it claims more than 50,000 lives

By |2024-05-10T16:31:19-04:00May 10th, 2024|Life Sciences, Life Sciences/Biotech|

Lake Superior State Offers Digital Mental Health Platform For Students

SAULT STE. MARIE–Lake Superior State University www.announced the launch of a new university-wide initiative designed to provide increased teletherapy and crisis support. In collaboration with the Natick, Mass.-based student mental health and wellness service provider Uwill, the university will increase its existing counseling capabilities with the addition of teletherapy that matches students with a licensed

By |2024-04-02T16:00:54-04:00April 2nd, 2024|Life Sciences, Life Sciences/Biotech|

LungVax Could Help Body Kill Cancer Cells And Stop Lung Cancer

OXFORD, UK - Scientists from the University of Oxford, the Francis Crick Institute and University College London have used technology similar to the Oxford-AstraZeneca COVID-19 vaccine to create the "LungVax," a vaccine which activates the immune system to kill cancer cells and stop lung cancer. The team has been granted up to $2 million in

By |2024-03-24T15:43:56-04:00March 24th, 2024|Life Sciences, Life Sciences/Biotech|

Pfizer To Build Cancer R&D Center In California, Rather Than Kalamazoo

SAN DIEGO, CA — Pfizer has announced it will soon expand its footprint into a 230,000 square-foot life science campus in San Diego to conduct cancer research. Pfizer Oncology announced last week it has signed a 15-year lease with Breakthrough Properties, a leading global life sciences real estate developer to move into a 10-acre Torrey

By |2024-03-24T15:43:56-04:00March 24th, 2024|Featured, Life Sciences, Life Sciences/Biotech|

Another Reason To Take Viagra: May Help Protect Against Alzheimer’s Disease

CLEVELAND, Ohio - A new study provides more evidence that sildenafil (Viagra) which is used to treat erectile dysfunction (ED) may help protect against Alzheimer's disease (AD). The large real-world analysis of patient data from two databases showed a 30%-54% reduced prevalence in AD among patients who took sildenafil (Viagra) than those who did not, after adjusting for potential

By |2024-03-24T13:19:59-04:00March 24th, 2024|Featured, Life Sciences, Life Sciences/Biotech|